Controls | OSAS | p-value | |
Subjects n | 119 | 119 | |
Glucose mg·dL−1 | 94±4 | 103±22 | 0.001 |
Triglycerides mg·dL−1 | 124±51 | 147±94 | 0.079 |
Cholesterol mg·dL−1 | 207±41 | 212±39 | 0.398 |
HDLc mg·dL−1 | 56±15 | 55±16 | 0.505 |
Creatinine mg·dL−1 | 0.88±0.2 | 0.96±0.3 | 0.692 |
Uric acid mg·dL−1 | 6.2±4.7 | 6.1±3.2 | 0.336 |
AST U·L−1 | 22±7 | 21±7 | 0.387 |
ALT U·L−1 | 27±15 | 27±13 | 0.809 |
GGT U·L−1 | 32±27 | 37±29 | 0.048 |
CRP U·L−1 | 1.4 (0.5–3.2) | 2.0 (0.9–3.6) | 0.01 |
8-isoprostanes U·L−1 | 4.3 (1.2–9.1) | 11.4 (6.1–22.5) | 0.001 |
FFAs mg·dL−1 | 10.5±5 | 12.2±5 | 0.015 |
Data are presented as mean±sd or median (interquartile range), unless otherwise stated. OSAS: obstructive sleep apnoea syndrome; HDLc: high-density lipoprotein-cholesterol; AST: aspartate aminotransferase; ALT: alanine aminotransferase; GGT: γ-glutamyltransferase; CRP: C-reactive protein; FFA: free fatty acid.